Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Where Will Pfizer Stock Be in 3 Years?


Investors should always consider the long game when looking at stocks. Even if a business is not doing well right now, that doesn't mean it'll always be the case. Looking at a broader time frame can help you identify promising long-term buys.

One stock that is an intriguing one to consider is Pfizer (NYSE: PFE). These days, it hasn't been a hot stock to own, not by any stretch. Investors are worried about its growth. Its recent results haven't been impressive, and while the dividend offers a high yield, there may be concerns about it as well. The result has been a stock that's been in deep trouble: in five years, Pfizer's stock has declined by close to 30%.

Below, I'll look at where the business might be in the next three years, and whether it's worth investing in the healthcare stock today.

Continue reading


Source Fool.com

Pfizer Inc. Stock

€23.14
1.650%
There is an upward development for Pfizer Inc. compared to yesterday, with an increase of €0.38 (1.650%).
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 29 € there is a positive potential of 25.35% for Pfizer Inc. compared to the current price of 23.14 €.
Like: 0
PFE
Share

Comments